215 related articles for article (PubMed ID: 33084530)
1. Serum lncRNA TINCR Serve as a Novel Biomarker for Predicting the Prognosis in Triple-Negative Breast Cancer.
Wang X; Li S; Xiao H; Deng X
Technol Cancer Res Treat; 2020; 19():1533033820965574. PubMed ID: 33084530
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of serum exosomal SUMO1P3 predicts unfavorable prognosis in triple negative breast cancer.
Na-Er A; Xu YY; Liu YH; Gan YJ
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):154-160. PubMed ID: 33506903
[TBL] [Abstract][Full Text] [Related]
3. The potential roles of lncRNA TINCR in triple negative breast cancer.
Azman AA; Siok-Fong C; Rajab NF; Md Zin RR; Ahmad Daud NN; Mohamad Hanif EA
Mol Biol Rep; 2023 Sep; 50(9):7909-7917. PubMed ID: 37442895
[TBL] [Abstract][Full Text] [Related]
4. LncRNA T376626 is a promising serum biomarker and promotes proliferation, migration, and invasion via binding to LAMC2 in triple-negative breast cancer.
He Y; Xiao B; Lei T; Xuan J; Zhu Y; Kuang Z; Liu J; He J; Li L; Sun Z
Gene; 2023 Apr; 860():147227. PubMed ID: 36709879
[TBL] [Abstract][Full Text] [Related]
5. Serum exosomal lncRNA XIST is a potential non-invasive biomarker to diagnose recurrence of triple-negative breast cancer.
Lan F; Zhang X; Li H; Yue X; Sun Q
J Cell Mol Med; 2021 Aug; 25(16):7602-7607. PubMed ID: 33949761
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of novel three-long noncoding RNA signatures as a diagnostic and prognostic biomarkers of human triple-negative breast cancer.
Fan CN; Ma L; Liu N
J Cell Biochem; 2019 Mar; 120(3):3185-3196. PubMed ID: 30203490
[TBL] [Abstract][Full Text] [Related]
7. LncRNA NEF is downregulated in triple negative breast cancer and correlated with poor prognosis.
Song X; Liu Z; Yu Z
Acta Biochim Biophys Sin (Shanghai); 2019 Apr; 51(4):386-392. PubMed ID: 30839051
[TBL] [Abstract][Full Text] [Related]
8. A three-long noncoding RNA signature as a diagnostic biomarker for differentiating between triple-negative and non-triple-negative breast cancers.
Liu M; Xing LQ; Liu YJ
Medicine (Baltimore); 2017 Mar; 96(9):e6222. PubMed ID: 28248879
[TBL] [Abstract][Full Text] [Related]
9. Imbalance of Molecular Module of TINCR-miR-761 Promotes the Metastatic Potential of Early Triple Negative Breast Cancer and Partially Offsets the Anti-Tumor Activity of Luteolin.
Zhang ML; Liu WW; Li WD
Cancer Manag Res; 2021; 13():1877-1886. PubMed ID: 33654432
[TBL] [Abstract][Full Text] [Related]
10. Long Non Coding RNA in Triple Negative Breast Cancer: A Promising Biomarker in Tumorigenesis.
Nandagopal S; Misra S; Sankanagoudar S; Banerjee M; Sharma P; Pane SE; Guerriero G; Shukla KK
Asian Pac J Cancer Prev; 2023 Jan; 24(1):49-59. PubMed ID: 36708551
[TBL] [Abstract][Full Text] [Related]
11. Circulating non‑coding RNA‑biomarker potential in neoadjuvant chemotherapy of triple negative breast cancer?
Ritter A; Hirschfeld M; Berner K; Rücker G; Jäger M; Weiss D; Medl M; Nöthling C; Gassner S; Asberger J; Erbes T
Int J Oncol; 2020 Jan; 56(1):47-68. PubMed ID: 31789396
[TBL] [Abstract][Full Text] [Related]
12. LncRNA TCONS_l2_00002973 correlates with less advanced tumor stage and favorable survival, and also inhibits cancer cells proliferation while enhancing apoptosis in triple-negative breast cancer.
Yan J; Wang R; Wu Z
J BUON; 2019; 24(2):535-542. PubMed ID: 31128002
[TBL] [Abstract][Full Text] [Related]
13. Trefoil factor 1 (TFF1) is a potential prognostic biomarker with functional significance in breast cancers.
Yi J; Ren L; Li D; Wu J; Li W; Du G; Wang J
Biomed Pharmacother; 2020 Apr; 124():109827. PubMed ID: 31986408
[TBL] [Abstract][Full Text] [Related]
14. Advances in Pathophysiology of Triple-Negative Breast Cancer: The Potential of lncRNAs for Clinical Diagnosis, Treatment, and Prognostic Monitoring.
Zhou Y; Yue Y; Fan S; Jia Q; Ding X
Mol Biotechnol; 2021 Dec; 63(12):1093-1102. PubMed ID: 34245439
[TBL] [Abstract][Full Text] [Related]
15. LncRNA LINC00173 enhances triple-negative breast cancer progression by suppressing miR-490-3p expression.
Fan H; Yuan J; Li X; Ma Y; Wang X; Xu B; Li X
Biomed Pharmacother; 2020 May; 125():109987. PubMed ID: 32058222
[TBL] [Abstract][Full Text] [Related]
16. TINCR expression is associated with unfavorable prognosis in patients with hepatocellular carcinoma.
Tian F; Xu J; Xue F; Guan E; Xu X
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28546230
[TBL] [Abstract][Full Text] [Related]
17. Proteomic investigation on bio-corona of Au, Ag and Fe nanoparticles for the discovery of triple negative breast cancer serum protein biomarkers.
Del Pilar Chantada-Vázquez M; López AC; Vence MG; Vázquez-Estévez S; Acea-Nebril B; Calatayud DG; Jardiel T; Bravo SB; Núñez C
J Proteomics; 2020 Feb; 212():103581. PubMed ID: 31731051
[TBL] [Abstract][Full Text] [Related]
18. lncRNA GAS5-promoted apoptosis in triple-negative breast cancer by targeting miR-378a-5p/SUFU signaling.
Zheng S; Li M; Miao K; Xu H
J Cell Biochem; 2020 Mar; 121(3):2225-2235. PubMed ID: 31692053
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA HUMT hypomethylation promotes lymphangiogenesis and metastasis via activating FOXK1 transcription in triple-negative breast cancer.
Zheng S; Yang L; Zou Y; Liang JY; Liu P; Gao G; Yang A; Tang H; Xie X
J Hematol Oncol; 2020 Mar; 13(1):17. PubMed ID: 32138762
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-β, insulin-like growth factor I/insulin-like growth factor I receptor and vascular endothelial growth factor-A: prognostic and predictive markers in triple-negative and non-triple-negative breast cancer.
Bahhnassy A; Mohanad M; Shaarawy S; Ismail MF; El-Bastawisy A; Ashmawy AM; Zekri AR
Mol Med Rep; 2015 Jul; 12(1):851-64. PubMed ID: 25824321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]